Enlivex, a longevity pharmaceutical company, has secured $21 million in debt financing
According to market news, Changshou Medicine and the RAIN token asset pool Enlivex announced that they have obtained $21 million in debt financing from the New York institutional fund The Lind Partners.
The company stated that it will continue to implement its predictive market token asset pool strategy, adding approximately 3 billion RAIN tokens, which will be used to support the company's operational plans. Enlivex is a Nasdaq-listed company that is developing therapies for joint diseases such as osteoarthritis, while holding a large position in RAIN as part of the RAIN digital asset pool. RAIN is a decentralized predictive market protocol token deployed on the Arbitrum network, which determines outcomes through AI and employs a buyback and burn mechanism. Enlivex's stock price is currently around $1.05, down about 5% for the day.
You may also like

Slow Down, That's the Answer to the Age of the Agent

From Cash to Cryptocurrency: Moving Towards a Unified Regulatory Path for Illegal Payments

Who will own the most Bitcoin in 2026

A private feud lasting 10 years, if not for OpenAI's "hypocrisy," would not have led to the world's strongest AI company, Anthropic

"Crypto Tsar" steps down: 130 days of political performance come to an end, how much of Trump's crypto promise remains?

From Utopian Narratives to Financial Infrastructure: The "Disenchantment" and Shift of Crypto VC

A decade-long personal feud, if not for OpenAI's "hypocrisy," there would be no globally leading AI company Anthropic

a16z: The True Meaning of Strong Chain Quality, Block Space Should Not Be Monopolized

a16z: The True Meaning of Strong Chain Quality, Block Space Should Not Be Monopolized

2% user contribution, 90% trading volume: The real picture of Polymarket

Trump Can't Take It Anymore, 5 Signals of the US-Iran Ceasefire

Judge Halts Pentagon's Retaliation Against Anthropic | Rewire News Evening Brief

Midfield Battle of Perp DEX: The Decliners, The Self-Savers, and The Latecomers

Iran War Stalemate: What Signal Should the Market Follow?

Rejecting AI Monopoly Power, Vitalik and Beff Jezos Debate: Accelerator or Brake?

Insider Trading Alert! Will Trump Call a Truce by End of April?

After establishing itself as the top tokenized stock, does Ondo have any new highlights?

